Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Yaron

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Clinical Obstetrics and Gynecology|March 21, 1998
What are the ethical and technical problems associated with multifetal pregnancy reduction?M I Evans, R L Kramer, Y Yaron, et al.
Prenatal Diagnosis|October 16, 1999
Fetal muscle biopsy as a diagnostic tool in Duchenne muscular dystrophyY Nevo, R Shomrat, Y Yaron, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 18, 2000
High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester lossM J Kupferminc, H Peri, E Zwang, et al.
Fertility and Sterility|June 1, 1996
Patients with Turner's syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donationY Yaron, Y Ochshorn, A Amit, et al.
American Journal of Obstetrics and Gynecology|March 1, 1994
Uterine rupture at 33 weeks' gestation subsequent to hysteroscopic uterine perforationY Yaron, M Shenhav, A J Jaffa, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 28, 1998
Malignant fibrous histiocytoma with myofibroblastic differentiation of the vulva in an adolescent femaleD Grisaru, M R Peyser, L Bernstein-Lipschitz, et al.
The Journal of Reproductive Medicine|June 15, 2000
p53 tumor suppressor gene expression in the mouse ovary during an artificially induced ovulatory cycleY Yaron, D Schwartz, M I Evans, et al.
Human Reproduction (Oxford, England)|September 18, 1998
Oocyte donation in Israel: a study of 1001 initiated treatment cyclesY Yaron, Y Ochshorn, A Amit, et al.
Prenatal Diagnosis|December 18, 2001
Effect of fetal gender on first trimester markers and on Down syndrome screeningY Yaron, I Wolman, M J Kupferminc, et al.
Prenatal Diagnosis|September 6, 2001
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophiliasY Ochshorn, M J Kupferminc, A Eldor, et al.
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Clinical Obstetrics and Gynecology|March 21, 1998
What are the ethical and technical problems associated with multifetal pregnancy reduction?M I Evans, R L Kramer, Y Yaron, et al.
Prenatal Diagnosis|October 16, 1999
Fetal muscle biopsy as a diagnostic tool in Duchenne muscular dystrophyY Nevo, R Shomrat, Y Yaron, et al.
Acta Obstetricia Et Gynecologica Scandinavica|November 18, 2000
High prevalence of the prothrombin gene mutation in women with intrauterine growth retardation, abruptio placentae and second trimester lossM J Kupferminc, H Peri, E Zwang, et al.
Fertility and Sterility|June 1, 1996
Patients with Turner's syndrome may have an inherent endometrial abnormality affecting receptivity in oocyte donationY Yaron, Y Ochshorn, A Amit, et al.
American Journal of Obstetrics and Gynecology|March 1, 1994
Uterine rupture at 33 weeks' gestation subsequent to hysteroscopic uterine perforationY Yaron, M Shenhav, A J Jaffa, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 28, 1998
Malignant fibrous histiocytoma with myofibroblastic differentiation of the vulva in an adolescent femaleD Grisaru, M R Peyser, L Bernstein-Lipschitz, et al.
The Journal of Reproductive Medicine|June 15, 2000
p53 tumor suppressor gene expression in the mouse ovary during an artificially induced ovulatory cycleY Yaron, D Schwartz, M I Evans, et al.
Human Reproduction (Oxford, England)|September 18, 1998
Oocyte donation in Israel: a study of 1001 initiated treatment cyclesY Yaron, Y Ochshorn, A Amit, et al.
Prenatal Diagnosis|December 18, 2001
Effect of fetal gender on first trimester markers and on Down syndrome screeningY Yaron, I Wolman, M J Kupferminc, et al.
Prenatal Diagnosis|September 6, 2001
Second-trimester maternal serum alpha-fetoprotein (MSAFP) is elevated in women with adverse pregnancy outcome associated with inherited thrombophiliasY Ochshorn, M J Kupferminc, A Eldor, et al.
Pageof 10